L. Myllykangas et al., Genetic association of alpha(2)-macroglobulin with Alzheimer's disease in a Finnish elderly population, ANN NEUROL, 46(3), 1999, pp. 382-390
Recently, two studies have reported an association between the alpha(2)-mac
roglobulin gene on chromosome 12 and late-onset Alzheimer's disease, wherea
s others have not been able to replicate these findings. By using a prospec
tive population-based study, we have investigated the relation between two
polymorphisms in this gene with the presence of the disease and also with t
he extent of pathological changes in the cerebral cortex. The Vantaa 85+ St
udy includes all 601 persons, at least 85 years of age, who were living in
Vantaa, Finland, on April 1, 1991. The neocortical beta -amyloid protein lo
ad and the number of neurofibrillary tangles were determined on tissue sect
ions by using methenamine silver staining and a modified Bielschowsky stain
ing, respectively. The A/A genotype in exon 24 of the alpha(2)-macroglobuli
n gene was associated with neuropathologically defined diagnosis of Alzheim
er's disease according to the CERAD (Consortium to Establish a Registry for
Alzheimer's Disease) criteria and with an increase in the neocortical beta
-amyloid protein load. The effect of this association was stronger in the a
polipoprotein E epsilon 4-negative group. Therefore, genetic variability in
the alpha(2)-macroglobulin gene is a risk factor associated with neuropath
ologically defined Alzheimer's disease in our population, as well as with t
he extent of neocortical P-amyloid protein deposition.